FDA and EMA approved specifically for weight loss
Weight loss typically triggers adaptive reductions in metabolic rate, which can slow further weight reduction and promote regain
Annu Rev Pharmacol Toxicol 47:14383, PMID: 17029566 Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, Chen K, Gabrielson KL, Blakely RD, Shih JC, Pacak K, Kass DA, Di Lisa F, Paolocci N (2010) Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload
Most data is extrapolated from individual peptide trials and animal models
If you have already injected medication that looked unusual, contact a licensed healthcare provider immediately